How severe is CVE-2014-5406?

CVE-2014-5406 has a CVSS 2.0 base score of 7.6, rated high severity.

Is CVE-2014-5406 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (66th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2014-5406?

CVE-2014-5406 affects Hospira Lifecare Pcainfusion Firmware. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2014-5406?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2014-5406 published?

CVE-2014-5406 was published on 2015-07-06 and last updated on 2026-06-17.

CVE-2014-5406

CVE-2014-5406 is a high-severity vulnerability in Hospira Lifecare Pcainfusion Firmware with a CVSS 2.0 base score of 7.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-345.

Key facts

Severity: High (CVSS 2.0 base score 7.6)
EPSS exploit prediction: 1% (66th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-345
Affected product: Hospira Lifecare Pcainfusion Firmware
Published: 2015-07-06
Last modified: 2026-06-17

Description

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

Frequently asked questions

What is CVE-2014-5406?: The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.
How severe is CVE-2014-5406?: CVE-2014-5406 has a CVSS 2.0 base score of 7.6, rated high severity.
Is CVE-2014-5406 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (66th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2014-5406?: CVE-2014-5406 affects Hospira Lifecare Pcainfusion Firmware. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2014-5406?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2014-5406 published?: CVE-2014-5406 was published on 2015-07-06 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:o:hospira:lifecare_pcainfusion_firmware:*:*:*:*:*:*:*:*

More vulnerabilities in Hospira Lifecare Pcainfusion Firmware

CVE-2015-3955 — Critical (CVSS 10.0): Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions,…
CVE-2015-3459 — Critical (CVSS 10.0): The communication module on the Hospira LifeCare PCA Infusion System before 7.0 does not require authentication for…
CVE-2015-3958 — High (CVSS 7.8): Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a…
CVE-2015-1011 — Medium (CVSS 5.0): Hospira LifeCare PCA Infusion System before 7.0 has hardcoded credentials, which makes it easier for remote attackers…
CVE-2015-3957 — Medium (CVSS 4.6): Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and…

All CVEs affecting Hospira Lifecare Pcainfusion Firmware →

Other CWE-345 (Insufficient Verification of Data Authenticity) vulnerabilities

CVE-2026-35051 — Critical (CVSS 10.0): Traefik is an HTTP reverse proxy and load balancer. Prior to versions 2.11.43, 3.6.14, and 3.7.0-rc.2, there is an…
CVE-2014-8165 — Critical (CVSS 10.0): scripts/amsvis/powerpcAMS/amsnet.py in powerpc-utils-python uses the pickle Python module unsafely, which allows remote…
CVE-2026-50195 — Critical (CVSS 9.9): containerd is an open-source container runtime. Versions prior to 2.3.2, 2.2.5 and 2.1.9 contain a vulnerability in the…
CVE-2022-36130 — Critical (CVSS 9.9): HashiCorp Boundary up to 0.10.1 did not properly perform data integrity checks to ensure the resources were associated…
CVE-2026-50214 — Critical (CVSS 9.8): The /v1/Plan service relies entirely on a shared global API token for full administrative management, allowing…
CVE-2025-15385 — Critical (CVSS 9.8): Insufficient Verification of Data Authenticity vulnerability in TECNO Mobile com.Afmobi.Boomplayer allows…

Browse all CWE-345 (Insufficient Verification of Data Authenticity) vulnerabilities →